A woman from Long Island was traveling over the holidays when she lost a beloved piece of jewelry that had been in her family for nearly a century -- and a group of strangers worked together to help ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The price increase comes after cocoa futures doubled toward the end of 2024, putting further pressure on food makers already ...

Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

Gary Stibel is the founder, CEO, and managing partner of the New England Consulting Group. With over half a century of experience, Gary has worked in nearly every segment of the healthcare and life ...

In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

Still, by my count, this year marks the first time in the 21st century that obesity ... One reason to think that this time is ...

With demand for GLP-1 drugs booming, compounding pharmacies and telehealth ... The AP is solely responsible for all content. For more than a century, Times Union photographers have been documenting ...

People with diabetes may have a lower risk of serious clots with GLP-1 drugs than with some other diabetes medications, a new study finds. People with diabetes may get fewer serious blood clots ...